a good response to early dmard treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
a multicentre, randomised, double blind, placebo controlled phase ii study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid ar..
assessing competencies in rheumatology
association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis
capability for daily activities in old people with rheumatoid arthritis: a population based study
case number 32: thiemann’s disease
chondroprotective activity of n-acetylglucosamine in rabbits with experimental osteoarthritis
contribution of polymorphisms in the apolipoprotein ai-ciii-aiv cluster to hyperlipidaemia in patients with gout
defining hip pain for population studies
evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
first line treatment of knee osteoarthritis in outpatients in france: adherence to the eular 2000 recommendations and factors influencing adherence
incidence and prevalence of complaints of the neck and upper extremity in general practice
is rheumatoid arthritis disappearing?
low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in ra synovium
pain and joint mobility explain individual subdimensions of the health assessment questionnaire (haq) disability index in patients with rheumatoid arthritis
patient centred outcomes in osteoarthritis
prevalence and predictors of fragility fractures in systemic lupus erythematosus
prevalence and determinants of one month hand pain and hand related disability in the elderly (rotterdam study)
prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary sj?gren’s syndrome
standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis
up regulated expression of fractalkine/cx3cl1 and cx3cr1 in patients with systemic sclerosis
using patients’ and rheumatologists’ opinions to specify a short form of the womac function subscale
validation and patient acceptance of a computer touch screen version of the womac 3.1 osteoarthritis index
when a dmard fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?